Résultats de la recherche

  • Flux RSS
(1 - 20 of 182)

Pages

Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
MOG-antibody neuromyelitis optica spectrum disorder: is it a separate disease?
Atypical forms of optic neuritis.
Spasticité et vie quotidienne dans la sclérose en plaques [= Spasticity and everyday life in multiple sclerosis]
Patient perceptions of multiple sclerosis and its treatment.
Current and future treatment approaches for neuromyelitis optica.
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.
Editorial [= Editorial]
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Deux nouveaux traitements par voie orale dans la sclérose en plaques rémittente [= Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Ocrelizumab for the treatment of multiple sclerosis
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.
Inflammatory-like presentation of CADASIL: a diagnostic challenge.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Robotic-assisted thymectomy with Da Vinci II versus sternotomy in the surgical treatment of non-thymomatous myasthenia gravis: early results.
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.

Pages

Islandora displays